Barclays PLC Evelo Biosciences, Inc. Transaction History

Barclays PLC

  • $327 Billion
  • Q2 2024

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 04, 2023
SELL
$0.17 - $1.57 $1,998 - $18,460
-11,758 Reduced 51.93%
10,883 $2,000
Q4 2022

Feb 13, 2023
BUY
$1.44 - $48.2 $28,280 - $946,599
19,639 Added 654.2%
22,641 $36,000
Q3 2022

Nov 03, 2022
BUY
$1.86 - $41.8 $5,583 - $125,483
3,002 New
3,002 $6,000
Q2 2022

Aug 12, 2022
SELL
$1.46 - $3.55 $7,199 - $17,505
-4,931 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$2.66 - $6.63 $84,941 - $211,715
-31,933 Reduced 86.62%
4,931 $17,000
Q4 2021

Feb 14, 2022
BUY
$6.07 - $12.0 $148,423 - $293,424
24,452 Added 197.0%
36,864 $224,000
Q3 2021

Nov 09, 2021
BUY
$6.79 - $13.9 $58,183 - $119,109
8,569 Added 222.98%
12,412 $87,000
Q2 2021

Aug 13, 2021
SELL
$9.43 - $16.6 $145,306 - $255,789
-15,409 Reduced 80.04%
3,843 $53,000
Q1 2021

May 13, 2021
BUY
$9.71 - $18.6 $124,278 - $238,061
12,799 Added 198.34%
19,252 $206,000
Q4 2020

Feb 11, 2021
SELL
$3.91 - $12.28 $10,091 - $31,694
-2,581 Reduced 28.57%
6,453 $78,000
Q3 2020

Nov 12, 2020
BUY
$3.81 - $5.73 $4,518 - $6,795
1,186 Added 15.11%
9,034 $48,000
Q2 2020

Aug 12, 2020
BUY
$3.53 - $6.12 $11,709 - $20,300
3,317 Added 73.21%
7,848 $38,000
Q1 2020

May 13, 2020
SELL
$3.21 - $7.06 $29,930 - $65,827
-9,324 Reduced 67.3%
4,531 $17,000
Q4 2019

Feb 10, 2020
BUY
$3.81 - $7.45 $26,814 - $52,433
7,038 Added 103.24%
13,855 $56,000
Q3 2019

Nov 14, 2019
SELL
$5.45 - $8.8 $11,848 - $19,131
-2,174 Reduced 24.18%
6,817 $41,000
Q2 2019

Aug 14, 2019
BUY
$6.52 - $9.42 $33,219 - $47,994
5,095 Added 130.78%
8,991 $81,000
Q1 2019

May 15, 2019
BUY
$7.5 - $15.31 $29,220 - $59,647
3,896 New
3,896 $31,000
Q4 2018

Feb 14, 2019
SELL
$7.29 - $13.01 $14,660 - $26,163
-2,011 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$11.93 - $14.76 $19,302 - $23,881
1,618 Added 411.7%
2,011 $24,000
Q2 2018

Aug 14, 2018
BUY
$11.39 - $16.26 $4,476 - $6,390
393 New
393 $5,000

About Evelo Biosciences, Inc.

EVLO Quotes by TradingView
  • Ticker EVLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,994,000
  • Description
  • Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hy...
More about EVLO
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email